Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $15,645.08 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 21,142 shares of the stock in a transaction on Wednesday, October 23rd. The stock was acquired at an average price of $0.74 per share, with a total value of $15,645.08. Following the completion of the acquisition, the chief executive officer now directly owns 14,794,794 shares of the company’s stock, valued at approximately $10,948,147.56. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Retractable Technologies Stock Down 2.7 %

Shares of RVP stock traded down $0.02 during trading hours on Thursday, hitting $0.72. 79,461 shares of the company were exchanged, compared to its average volume of 88,255. Retractable Technologies, Inc. has a 52 week low of $0.71 and a 52 week high of $1.34. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01. The business has a 50 day moving average of $0.85 and a two-hundred day moving average of $1.00.

Retractable Technologies (NYSE:RVP) last announced its earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The company had revenue of $6.03 million during the quarter.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Retractable Technologies in a research report on Friday, October 18th. They issued a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.